{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:40:41Z","timestamp":1792478441733,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","psychiatricnursing.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Psychiatric Nursing"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.apnu.2022.06.001","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T01:51:05Z","timestamp":1654480265000},"page":"106-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Venlafaxine-related galactorrhea in an adolescent female: A case report"],"prefix":"10.1016","volume":"40","author":[{"given":"Brayden N.","family":"Kameg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.apnu.2022.06.001_bb0005","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/13651501.2018.1425459","article-title":"Prevalence and risk factors of hyperprolactinemia among patients with various psychiatric diagnoses and medications","volume":"22","author":"Alosaimi","year":"2018","journal-title":"International Journal of Psychiatry in Clinical Practice"},{"key":"10.1016\/j.apnu.2022.06.001_bb0010","first-page":"179","article-title":"Reversible normoprolactinemic galactorrhea in major depressive disorder with a stable dose of fluoxetine: A case report","volume":"29","author":"Ayd","year":"2019","journal-title":"Klinik Psikofarmakoloji Bulteni"},{"issue":"1","key":"10.1016\/j.apnu.2022.06.001_bb0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.22270\/jddt.v10i1.3865","article-title":"Psychotic disorders, definition, sign and symptoms, antipsychotic drugs, mechanism of action, pharmacokinetics & pharmacodynamics with side effects & adverse drug reactions: Updated systematic review article","volume":"10","author":"Bangwal","year":"2020","journal-title":"Journal of Drug Delivery and Therapeutics"},{"issue":"2","key":"10.1016\/j.apnu.2022.06.001_bb0020","doi-asserted-by":"crossref","first-page":"181","DOI":"10.9758\/cpn.2017.15.2.181","article-title":"Dose dependent course of hyperprolactinemic and normoprolactinemic galactorrhea induced by venlafaxine","volume":"15","author":"Camkurt","year":"2017","journal-title":"Clinical Psychopharmacology and Neuroscience"},{"issue":"4","key":"10.1016\/j.apnu.2022.06.001_bb0025","first-page":"S15","article-title":"Correction of normoprolactinemic galactorrhea following treatment with sympathomimetic amines","volume":"89","author":"Check","year":"2008","journal-title":"Fertility and Sterility"},{"issue":"09","key":"10.1016\/j.apnu.2022.06.001_bb0030","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1055\/s-2007-1018749","article-title":"Prolactin lowering effect of amphetamine in normoprolactinemic subjects and in physiological and pathological hyperprolactinemia","volume":"15","author":"DeLeo","year":"1983","journal-title":"Hormone and Metabolic Research"},{"issue":"8","key":"10.1016\/j.apnu.2022.06.001_bb0035","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00406-021-01241-3","article-title":"Galactorrhea during antipsychotic treatment: Results from AMSP, a drug surveillance program, between 1993 and 2015","volume":"271","author":"Glocker","year":"2021","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"3","key":"10.1016\/j.apnu.2022.06.001_bb0040","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2190\/PM.37.3.d","article-title":"A case with euprolactinemic galactorrhea induced by escitalopram","volume":"37","author":"Gulsun","year":"2007","journal-title":"The International Journal of Psychiatry in Medicine"},{"key":"10.1016\/j.apnu.2022.06.001_bb0045","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9253083","article-title":"Stress-induced hyperprolactinemia: pathophysiology and clinical approach","volume":"2018","author":"Levine","year":"2018","journal-title":"Obstetrics and Gynecology International"},{"key":"10.1016\/j.apnu.2022.06.001_bb0050","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jad.2019.03.006","article-title":"Aripiprazole for the treatment of duloxetine induced hyperprolactinemia: A case report","volume":"250","author":"Luo","year":"2019","journal-title":"Journal of Affective Disorders"},{"issue":"4","key":"10.1016\/j.apnu.2022.06.001_bb0055","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2165\/00003495-198325040-00004","article-title":"Prolactin lowering and-releasing drugs","volume":"25","author":"M\u00fcller","year":"1983","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.apnu.2022.06.001_bb0060","first-page":"42","article-title":"Strategies for managing medication-induced hyperprolactinemia","volume":"17","author":"Navy","year":"2018","journal-title":"Current Psychiatry"},{"issue":"S1","key":"10.1016\/j.apnu.2022.06.001_bb0065","first-page":"1","article-title":"Galactorrhea associated with sertraline: A case report and literature review","volume":"30","author":"Ouanes","year":"2015","journal-title":"European Psychiatry"},{"issue":"1","key":"10.1016\/j.apnu.2022.06.001_bb0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1515\/tjb-2018-0106","article-title":"Galactorrhea and hyperprolactinemia during vortioxetine use: Case report","volume":"44","author":"\u00d6zkan","year":"2019","journal-title":"Turkish Journal of Biochemistry"},{"issue":"4","key":"10.1016\/j.apnu.2022.06.001_bb0075","first-page":"294","article-title":"Duloxetine associated galactorrhea and hyperprolactinemia: A case report","volume":"31","author":"\u00d6zkan","year":"2020","journal-title":"Turk Psikiyatri Dergisi"},{"issue":"December","key":"10.1016\/j.apnu.2022.06.001_bb0080","article-title":"Hyperprolactinemia: The ABCs of diagnosis and management","author":"Somerall","year":"2020","journal-title":"Women's Healthcare"},{"issue":"1","key":"10.1016\/j.apnu.2022.06.001_bb0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00004714-200302000-00023","article-title":"Venlafaxine-induced galactorrhea","volume":"23","author":"Sternbach","year":"2003","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1016\/j.apnu.2022.06.001_bb0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/psychiatry.IndianJPsychiatry_317_17","article-title":"Galactorrhea with antidepressants: A case series","volume":"60","author":"Suthar","year":"2018","journal-title":"Indian Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.apnu.2022.06.001_bb0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000499694","article-title":"Pitfalls in the diagnostic evaluation of hyperprolactinemia","volume":"109","author":"Vilar","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"4","key":"10.1016\/j.apnu.2022.06.001_bb0100","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/JCP.0000000000000514","article-title":"Venlafaxine-associated euprolactinemic galactorrhea and hypersexuality: A case report and review of the literature","volume":"36","author":"Warren","year":"2016","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"10.1016\/j.apnu.2022.06.001_bb0105","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/JCP.0b013e318185a719","article-title":"A case of venlafaxine-induced galactorrhea?","volume":"28","author":"Wichman","year":"2008","journal-title":"Journal of Clinical Psychopharmacology"}],"container-title":["Archives of Psychiatric Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883941722000565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883941722000565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:33:35Z","timestamp":1760124815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883941722000565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":21,"alternative-id":["S0883941722000565"],"URL":"https:\/\/doi.org\/10.1016\/j.apnu.2022.06.001","relation":{},"ISSN":["0883-9417"],"issn-type":[{"value":"0883-9417","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Venlafaxine-related galactorrhea in an adolescent female: A case report","name":"articletitle","label":"Article Title"},{"value":"Archives of Psychiatric Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apnu.2022.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}